News
FDA approves new labeling for Embeda ER capsules
On Oct. 17, the U.S. Food and Drug Administration (FDA) approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, an…
FDA approves two drugs for idiopathic pulmonary fibrosis
On Oct. 15, the U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm and Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis.…
FDA issues recommendations for strengthening cybersecurity of devices
On Oct. 1, the U.S. Food and Drug Administration (FDA) finalized recommendations to manufacturers for managing cybersecurity risks to better protect patient health and…
FDA clears glucose monitoring system for use in critically ill patients.
On September 24, the U.S. Food and Drug Administration (FDA) cleared a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its…
FDA approves treatment for opioid-induced constipation
On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer…
FDA approves new labeling for Embeda ER capsules
On Oct. 17, the U.S. Food and Drug Administration (FDA) approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER)…
FDA approves two drugs for idiopathic pulmonary fibrosis
On Oct. 15, the U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm and Esbriet (pirfenidone) for the treatment of idiopathic…
FDA issues recommendations for strengthening cybersecurity of devices
On Oct. 1, the U.S. Food and Drug Administration (FDA) finalized recommendations to manufacturers for managing cybersecurity risks to better protect patient…
FDA clears glucose monitoring system for use in critically ill patients.
On September 24, the U.S. Food and Drug Administration (FDA) cleared a new indication for the Nova StatStrip Glucose Hospital Meter System,…
FDA approves treatment for opioid-induced constipation
On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with…
Test Your Knowledge
Cannabis TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.